scholarly journals Combined thiazolidinedione–metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle

Diabetologia ◽  
2008 ◽  
Vol 52 (1) ◽  
pp. 60-64 ◽  
Author(s):  
N. Temofonte ◽  
M. P. Sajan ◽  
S. Nimal ◽  
T. Pastoor ◽  
C. Fumero ◽  
...  
2005 ◽  
Vol 280 (38) ◽  
pp. 32693-32699 ◽  
Author(s):  
Karsten Müssig ◽  
Harald Staiger ◽  
Hendrik Fiedler ◽  
Klaus Moeschel ◽  
Alexander Beck ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-8
Author(s):  
Christine Zhiwen Hu ◽  
Jaswinder K. Sethi ◽  
Thilo Hagen

Background. SOCS proteins are known to negatively regulate insulin signaling by inhibiting insulin receptor substrate-1 (IRS1). IRS1 has been reported to be a substrate for ubiquitin-dependent proteasomal degradation. Given that SOCS proteins can function as substrate receptor subunits of Cullin-5 E3 ubiquitin ligases, we examined whether Cullin-5 dependent ubiquitination is involved in the regulation of basal IRS1 protein stability and signal-induced IRS1 degradation.Findings. Our results indicate that basal IRS1 stability varies between cell types. However, the Cullin-5 E3 ligase does not play a major role in mediating IRS1 ubiquitination under basal conditions. Protein kinase C activation triggered pronounced IRS1 destabilization. However, this effect was also independent of the function of Cullin-5 E3 ubiquitin ligases.Conclusions. In conclusion, SOCS proteins do not exert a negative regulatory effect on IRS1 by functioning as substrate receptors for Cullin-5-based E3 ubiquitin ligases both under basal conditions and when IRS1 degradation is induced by protein kinase C activation.


2008 ◽  
Vol 283 (17) ◽  
pp. 11226-11233 ◽  
Author(s):  
Rizwana Sanaullah Waraich ◽  
Cora Weigert ◽  
Hubert Kalbacher ◽  
Anita M. Hennige ◽  
Stefan Z. Lutz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document